| Value | ₹1.40 Cr |
|---|
BSE filing, NSE: A2ZINFRA. Summary written from the filing by ALFA Finder's alert engine.
A2Z Infra Engineering Ltd: key numbers
- Share price
- ₹13.74
- Market cap
- ₹243.9 Cr
- Revenue (annual)
- ₹386.4 Cr
- Net profit (annual)
- ₹4.37 Cr
- P/E (TTM)
- 66.6×Sector 31.3×
- Promoter holding
- 27.92%+0.00% QoQ
- FII holding
- 1.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from A2Z Infra Engineering Ltd
All →A2Z Infra Engineering Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI Regulation 31(1)(b).
A2Z Infra Engineering Management Change
Shareholders of A2Z Infra Engineering Ltd approved the re-appointment of Mr. Amit Mittal as Managing Director cum CEO for three years, effective January 1, 2027.
A2Z Infra Engineering Annual General Meeting
A2Z Infra Engineering held its 25th Annual General Meeting on September 26, 2026. The meeting discussed financial statements, director appointments, and auditor re-appointments.
A2Z Infra Engineering Other Announcement
A2Z Infra Engineering Ltd has dispatched letters to shareholders with unregistered email IDs, providing the weblink for the Annual Report and 25th AGM notice.
A2Z Infra Engineering Annual General Meeting
A2Z Infra Engineering Ltd has scheduled its 25th Annual General Meeting for September 26, 2026, through video conferencing. The meeting includes appointments of auditors and directors.
A2Z Infra Engineering Management Change
A2Z Infra Engineering Limited reported the re-appointment of its statutory auditor, MRKS and Associates, and executive director Amit Mittal. These appointments were approved by the board.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date